A Breakthrough Immunoassay
A Breakthrough Immunoassay
Media & Downloads

Nu.Q® Discover: Nu.Q® H3.1: A Breakthrough Immunoassay for Reliable and Robust NETs Quantification.

July 07, 2025
Screenshot 2025-07-07 141127
Screenshot 2025-07-07 141127

Nu.Q® H3.1 is an advanced chemiluminescent immunoassay engineered for accurate and standardized quantification of neutrophil extracellular traps (NETs) via H3.1-nucleosomes in plasma. Nu.Q® H3.1 delivers high specificity and reproducibility, making it ideal for studying NET-related pathologies such as sepsis, COVID-19, and autoimmune diseases.

Download our application notes to find out more about this assay.